Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Theravance Biopharma, Inc. (TBPH)  
$8.62 0.13 (1.53%) as of 4:30 Fri 5/31


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 63,980,000
Market Cap: 551.51(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $8.22 - $11.59
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    : 18.6
Insider 6 Months    : 18.6
Insider 3/6 Months : 37.7
Guru Rank Number :  245
Guru Rank Value     : 4.8
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Theravance Biopharma is a biopharmaceutical company primarily focused on the discovery, development and commercialization of respiratory medicine medicines. Co.'s program include: YUPELRI™ (revefenacin) inhalation solution, nebulized long-acting muscarinic antagonist for the maintenance treatment of chronic obstructive pulmonary disease; and Lung-selective, Nebulized Pan-Janus Kinase (JAK) Inhibitor (Nezulcitinib), a lung-selective, nebulized JAK inhibitor, in clinical development for the potential treatment of hospitalized patients with acute lung injury caused by Coronavirus Disease 2019.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 1,499,124 1,499,124 1,499,124 1,499,124
Total Buy Value $13,117,335 $13,117,335 $13,117,335 $13,117,335
Total People Bought 1 1 1 1
Total Buy Transactions 1 1 1 1
Total Shares Sold 0 1,254 20,641 171,008
Total Sell Value $0 $10,922 $205,329 $1,825,540
Total People Sold 0 1 2 4
Total Sell Transactions 0 1 10 20
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 543
  Page 1 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Sawaf Aziz SVP & CHIEF FINANCIAL OFFICER   •       –      –    2024-05-20 4 D $9.10 $78,579 D/D (8,635) 330,001     -
   Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY   •       –      –    2024-05-20 4 D $9.10 $84,339 D/D (9,268) 351,881     -
   Winningham Rick E CHIEF EXECUTIVE OFFICER   •       •      –    2024-05-20 4 D $9.10 $145,573 D/D (15,997) 1,836,644     -
   Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS   •       –      –    2024-05-20 4 D $9.10 $84,339 D/D (9,268) 339,965     -
   Miller Aine SVP, DEV & HEAD OF IRE OFFICE   •       –      –    2024-05-20 4 D $9.10 $47,329 D/D (5,201) 165,833     -
   Winningham Rick E CHIEF EXECUTIVE OFFICER   •       •      –    2024-05-15 4 A $9.85 $20,370 D/D 2,068 1,852,641     -
   Broshy Eran   –       •      –    2024-05-08 4 A $0.00 $0 D/D 10,537 80,555     -
   Grant Jeremy T   –       •      –    2024-05-08 4 A $0.00 $0 D/D 10,537 22,305     -
   Pakianathan Deepika   –       •      –    2024-05-08 4 A $0.00 $0 D/D 10,537 47,416     -
   Oconnor Donal   –       •      –    2024-05-08 4 A $0.00 $0 D/D 10,537 63,555     -
   Mitchell Dean J   –       •      –    2024-05-08 4 A $0.00 $0 D/D 10,537 80,555     -
   Gray Susannah   –       •      –    2024-05-08 4 A $0.00 $0 D/D 10,537 31,488     -
   Smaldone Alsup Laurie   –       •      –    2024-05-08 4 A $0.00 $0 D/D 10,537 64,331     -
   Samaha Eli 10% Owner   –       –       •   2024-05-01 4 B $8.75 $13,117,335 I/I 1,499,124 8,511,350 1.5 -2%     
   Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS   •       –      –    2024-04-02 4 A $0.00 $0 D/D 37,500 349,233     -
   Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY   •       –      –    2024-04-02 4 A $0.00 $0 D/D 100,000 360,684     -
   Sawaf Aziz SVP & CHIEF FINANCIAL OFFICER   •       –      –    2024-04-02 4 A $0.00 $0 D/D 100,000 338,636     -
   Miller Aine SVP, DEV & HEAD OF IRE OFFICE   •       –      –    2024-04-02 4 A $0.00 $0 D/D 37,500 171,034     -
   Winningham Rick E CHIEF EXECUTIVE OFFICER   •       •      –    2024-04-02 4 A $0.00 $0 D/D 300,000 1,850,573     -
   Winningham Rick E CHIEF EXECUTIVE OFFICER   •       •      –    2024-03-15 4 GA $0.00 $0 I/I 3,900 3,900     -
   Winningham Rick E CHIEF EXECUTIVE OFFICER   •       •      –    2024-03-15 4 GD $0.00 $0 D/D 10,900 1,550,573     -
   Winningham Rick E CHIEF EXECUTIVE OFFICER   •       •      –    2024-03-15 4 A $8.64 $23,363 D/D 2,704 1,561,473     -
   Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS   •       –      –    2024-02-22 4 AS $8.71 $10,922 D/D (1,254) 311,733 -1%     
   Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS   •       –      –    2024-02-20 4 D $8.92 $162,513 D/D (18,219) 312,987     -
   Winningham Rick E CHIEF EXECUTIVE OFFICER   •       •      –    2024-02-20 4 D $8.92 $331,788 D/D (37,196) 1,558,769     -

  543 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed